VisionWave’s 1-for-20 Reverse Stock Split Takes Effect in Nasdaq Compliance Push

VisionWave Holdings’ 1-for-20 reverse stock split became effective at 12:01 a.m. Eastern Time on September 22, reducing the defense technology company’s outstanding common shares to roughly one-twentieth of their previous count as it works to satisfy Nasdaq’s minimum bid-price requirement.

The company said its common stock will continue trading on the Nasdaq Global Market under the symbol VWAV and was expected to begin trading on a split-adjusted basis at the September 22 market open. A new CUSIP number, 927950204, applies to the common stock after the split.

Under the September 18 Form 8-K, every 20 shares issued and outstanding immediately before the effective time were automatically converted into one share. VisionWave estimated that its outstanding share count would fall from about 47.5 million to approximately 2.4 million, subject to adjustments caused by the treatment of fractional shares.

What the 1-for-20 split changes for VisionWave shareholders

A reverse split changes the number of shares held and the per-share reference price, but it does not by itself create additional economic value. A holder with 2,000 shares immediately before a 1-for-20 split would generally hold 100 shares afterward, before accounting for any fractional-share treatment. The market price per share is mechanically adjusted upward by the same ratio at the outset, although the stock can move independently once trading resumes.

VisionWave will not issue fractional shares. If the calculation would leave a holder with a fraction, the company said that fraction will be rounded up to the next whole share after all shares held of record by that holder are aggregated. Holders will not receive cash instead of a fractional share, and the company said no stockholder will be cashed out because of the split.

The split also leaves several parts of VisionWave’s capital structure unchanged. The common stock’s par value remains $0.01 per share. The company is still authorized to issue 160 million shares of capital stock, consisting of 150 million common shares and 10 million preferred shares. Because the number of outstanding common shares falls sharply while the authorized total stays the same, the amount of authorized but unissued common stock increases substantially relative to the shares currently outstanding.

VisionWave explicitly warned that future issuances from that pool could dilute existing shareholders. That point has added relevance because the company separately entered an at-the-market sales agreement with Aegis Capital on September 18 that permits it to sell up to $30 million of common stock from time to time. The financing arrangement is separate from the reverse split, but both affect how investors should read the company’s post-split share structure.

The Nasdaq test is not satisfied by the split alone

VisionWave said the reverse split is primarily intended to raise its per-share trading price so it can maintain compliance with the $1 minimum bid-price requirement for continued listing on the Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1) sets a minimum bid price of $1 per share for a primary equity security listed on the Global Market.

The split can put the quoted share price above that threshold mechanically, but it does not by itself establish that the company has regained or will maintain compliance. Nasdaq’s deficiency process generally requires the applicable bid-price standard to be met for a minimum of 10 consecutive business days, with staff able to require a longer period in some circumstances. Other continued-listing standards also remain applicable.

That distinction is important because reverse splits can address the arithmetic of a low share price without resolving the factors that pushed a stock below the threshold in the first place. VisionWave acknowledged that risk in its filing, noting that the split may not result in a sustained increase in the per-share trading price. The company also identified reduced liquidity and possible dilution from future issuances of authorized but unissued shares among the risks surrounding the action.

The company’s stockholders had already given the board considerably more flexibility than it ultimately used. At VisionWave’s September 1 annual meeting, shareholders approved an amendment allowing a reverse split at a ratio of up to 1-for-250, with the exact ratio and timing left to the board. The board selected 1-for-20 on September 3, and VisionWave filed the corresponding certificate of amendment with Delaware on September 16.

Share count falls, but the compliance question remains open

The immediate effect is straightforward: VisionWave now has far fewer common shares outstanding, and each post-split share represents 20 pre-split shares. Existing holders generally retain the same proportional ownership immediately after the adjustment, apart from the company’s rounding treatment and any later changes in the share count. The reverse split also does not alter the company’s underlying operations, assets or liabilities simply because the number of shares has changed.

For investors, the next meaningful issue is whether VWAV can sustain a closing bid price that satisfies Nasdaq’s continued-listing standard. A post-split price above $1 on the first trading day would not, on its own, close that question. Compliance depends on maintaining the required price for the applicable period and continuing to meet the exchange’s other standards.

The unchanged authorized-share limit is another point to watch after the split. With approximately 2.4 million shares expected to be outstanding immediately afterward, the gap between outstanding shares and the 150 million common shares authorized under VisionWave’s charter becomes much wider on a relative basis. The company has already cautioned that future issuance of those shares could dilute current holders.

VisionWave describes itself as a defense and advanced sensing technology company developing artificial-intelligence-driven radio-frequency sensing, autonomy and computational acceleration technologies. For the September 22 market session, however, the central issue is the capital structure: the 1-for-20 split is now effective, but the company still has to demonstrate sustained compliance with Nasdaq’s bid-price requirement rather than relying on the split itself as the endpoint.